gluten and dyspepsia

Gluten and dyspepsia

1 Celiac disease (CD) affects approximately 1% of the population. It is a disease that causes flattening of the epithelial lining of the small bowel and is characterized by (sub) total villous atrophy. The histological alterations in CD are graded according to the modified Marsh Classification from Marsch 0 (normal mucosa) to Marsch IIIc (total villous atrophy). Common symptoms include, but are...

Gluten associated dyspepsia; serology and histological characteristics

AIM The aim of this study was to assess the prevalence of celiac disease (CD) in dyspeptic patients. BACKGROUND Although severe mucosal abnormality with villous atrophy (lesions Marsh III) is the histology gold standard for the diagnosis of CD, non-specific microenteropathy (Marsh I-II) with positive serology is also common Patients with dyspepsia, specific CD antibodies and microenteropathy,...

gluten associated dyspepsia; serology and histological characteristics

aim : the aim of this study was to discuss the prevalence of celiac disease (cd) in dyspeptic patients. background : although severe mucosal abnormality with villous atrophy (lesions marsh iii) is at present the gold standard for the diagnosis of cd, presentation with non-specific microenteropathy (marsh i-ii) with positive serology is also common. patients with dyspepsia, specific cd antibodie...

Spectrum of gluten-sensitive enteropathy in patients with dysmotility-like dyspepsia.

BACKGROUND Dysmotility-like dyspepsia symptoms are frequent in patients with gluten-sensitive enteropathy (GSE). Current data suggest that patients with mild enteropathy may be present with gluten-sensitive symptoms and complications. AIM To investigate the prevalence of GSE, including mild enteropathy, in patients with dysmotility-like dyspepsia symptoms. METHODS We retrospectively studied...

Gluten intolerance, gluten enteropathy, and coeliac disease.

DYSPEPSIA MANAGEMENT Approaches to uninvestigated dyspepsia

Uninvestigated dyspepsia refers to patients with new or recurrent dyspeptic symptoms in whom no investigations have previously been undertaken. These patients are much more likely to present in primary than in secondary care. It is particularly important to be able to offer effective symptom relief to support the explanation, reassurance, and advice provided to patients, and low dose or standar...